Ultra low Mammaprint Score - Aromatase Inhibitors

I’m bringing a more specific detail to the Aromatase Inhibitors discussions. Is there anyone here who has an Ultra Low Risk Mammoprint score who chose to forego endocrine therapy completely? I’ve reviewed the MINDACT and FLEX studies and I’m having a hard time convincing myself that taking an AI (specifically Letrozole) isn’t over treatment. Per the MINDACT study and my specific results, the difference in distant metastasis is negligible whether I take it or not. One oncologist is comfortable with my decision to forego and my second opinion wants me to give a try and see how I do. I’m 56, post menopausal and already deal with most of the issues listed as fairly common side effects. Invasive lobular Cancer Stage 1 HR+/HER2- with no node involvement. Anyone out there? It’s so hard to find anyone because standard of care is to take them for 5 years regardless and then decide whether longer is appropriate.